Aegros' chief executive, Damian Thornton, a 35‑year industry veteran brought in after a financial and board restructure, said the company’s 2025 capital raise was pivotal in addressing prior debt issues and unlocking completion of the facility without further government funding beyond R&D tax incentives. …
Aegros completes Australia’s second large scale plasma fractionation plant
July 8, 2026 Latest NewsAustralian BiotechBioPharma
Latest Video
New Stories
-
If this is an example of a bully playing hardball, it's not the companies
July 21, 2026 - - Latest News -
LTR Pharma secures national US manufacturing and fulfilment partner
July 21, 2026 - - Latest News -
Candidate shows antidepressant signal in difficult to treat depression
July 21, 2026 - - Latest News -
'Our access. Our medicines. Our vaccines. Our medical technology'
July 21, 2026 - - Latest News -
Novartis names Anne Harris to lead Australia and New Zealand
July 20, 2026 - - Latest News -
Why is the system slower than when there was no patient involvement or input?
July 20, 2026 - - Latest News -
No company in its right mind would risk a large private market for this outcome?
July 20, 2026 - - Latest News